HEATHER DALWADI: Open Payments
NPI 1922275890 · PIKESVILLE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 28 payments from 13 companies in 2025. Trend: 2023 $937 · 2024 $610 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 2 | $250 |
| Novo Nordisk Inc | 11 | $165 |
| Lilly USA, LLC | 2 | $112 |
| Inspire Medical Systems, Inc. | 1 | $101 |
| Radius Health, Inc. | 3 | $68 |
| Amneal Pharmaceuticals LLC | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
| Medtronic, Inc. | 1 | $24 |
| Insulet Corporation | 1 | $23 |
| Abbott Laboratories | 1 | $20 |
Products named: Korlym, Ozempic, INSPIRE, ZEPBOUND, UNITHROID, Kerendia, MINIMED 780G, Omnipod.
Industry payments across MD — which companies pay providers there.
